Olivia Belbin
Impact in
- Physiology top 2%
- Alzheimer's disease research and treatments
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
- Amyotrophic Lateral Sclerosis Research
Papers in
- Physiology 33
- Alzheimer's disease research and treatments 32
- Co-authors
- Alberto Lleó (32 shared papers)Jordi Clarimón (12 shared papers)Juan Fortea (24 shared papers)Jordi Pegueroles (12 shared papers)Martí Colom‐Cadena (6 shared papers)Kevin Morgan (13 shared papers)Rafael Blesa (10 shared papers)Daniel Alcolea (17 shared papers)
- Journals
- Neurobiology of Aging (6 papers)Alzheimer s & Dementia (5 papers)Journal of Alzheimer s Disease (5 papers)Molecular Neurodegeneration (4 papers)Alzheimer s Research & Therapy (3 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Olivia Belbin
49 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Physiology 875
- Neurology 264
- Biological Psychiatry 72
- Psychiatry and Mental health 263
- Neurology 248
Countries citing papers authored by Olivia Belbin
This map shows the geographic impact of Olivia Belbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Belbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Belbin more than expected).
Fields of papers citing papers by Olivia Belbin
This network shows the impact of papers produced by Olivia Belbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Belbin. The network helps show where Olivia Belbin may publish in the future.
Co-authors
The 25 scholars most cited alongside Olivia Belbin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 168 | |
| 2 | APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease Hit paper breakdown → | 2024 | 140 |
| 3 | 2013 | 140 | |
| 4 | 2018 | 124 | |
| 5 | 2017 | 102 | |
| 6 | 2019 | 58 | |
| 7 | 2011 | 58 | |
| 8 | 2020 | 57 | |
| 9 | 2011 | 54 | |
| 10 | 2010 | 47 | |
| 11 | 2007 | 45 | |
| 12 | 2017 | 40 | |
| 13 | 2012 | 39 | |
| 14 | 2013 | 34 | |
| 15 | 2014 | 31 | |
| 16 | 2020 | 24 | |
| 17 | 2010 | 19 | |
| 18 | 2016 | 19 | |
| 19 | 2019 | 17 | |
| 20 | 2022 | 16 |
About Olivia Belbin
Olivia Belbin is a scholar working on Physiology, Molecular Biology, Cellular and Molecular Neuroscience, Genetics and Psychiatry and Mental health, having authored 51 papers that have together received 1.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (32 papers), Dementia and Cognitive Impairment Research (8 papers), Genetic Associations and Epidemiology (8 papers), Neuroscience and Neuropharmacology Research (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Nuclear Receptors and Signaling (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). The work is most often cited by research in Physiology (875 citations), Neurology (264 citations), Biological Psychiatry (72 citations), Psychiatry and Mental health (263 citations) and Neurology (248 citations). Olivia Belbin has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Alberto Lleó, Jordi Clarimón, Juan Fortea, Jordi Pegueroles, Martí Colom‐Cadena, Kevin Morgan, Rafael Blesa, Daniel Alcolea, Talisha A. Hunter and Neill R. Graff‐Radford. Their work appears in journals such as Neurobiology of Aging, Alzheimer s & Dementia, Journal of Alzheimer s Disease, Molecular Neurodegeneration and Alzheimer s Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.